Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PROTAC PTK6 ligand-1

😃Good
Catalog No. T77928Cas No. 2408341-98-8

PROTAC PTK6 ligand-1 is a functional intermediate used in the preparation of BTK kinase inhibitors and serves as a key synthetic building block for proteolysis-targeting chimera development, including the synthesis of ARD-61, PROTAC PTK6 ligand-1 enables targeted protein degradation studies and facilitating advanced medicinal chemistry research focused on kinase-driven disease models.

PROTAC PTK6 ligand-1

PROTAC PTK6 ligand-1

😃Good
Catalog No. T77928Cas No. 2408341-98-8
PROTAC PTK6 ligand-1 is a functional intermediate used in the preparation of BTK kinase inhibitors and serves as a key synthetic building block for proteolysis-targeting chimera development, including the synthesis of ARD-61, PROTAC PTK6 ligand-1 enables targeted protein degradation studies and facilitating advanced medicinal chemistry research focused on kinase-driven disease models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
PROTAC PTK6 ligand-1 is a functional intermediate used in the preparation of BTK kinase inhibitors and serves as a key synthetic building block for proteolysis-targeting chimera development, including the synthesis of ARD-61, PROTAC PTK6 ligand-1 enables targeted protein degradation studies and facilitating advanced medicinal chemistry research focused on kinase-driven disease models.
Chemical Properties
Molecular Weight540.63
FormulaC27H32N4O6S
Cas No.2408341-98-8
SmilesC([C@H](C(C)C)C1=CC(C)=NO1)(=O)N2[C@H](C(N[C@@H](CC(O)=O)C3=CC=C(C=C3)C4=C(C)N=CS4)=O)C[C@@H](O)C2
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (147.98 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8497 mL9.2485 mL18.4969 mL92.4847 mL
5 mM0.3699 mL1.8497 mL3.6994 mL18.4969 mL
10 mM0.1850 mL0.9248 mL1.8497 mL9.2485 mL
20 mM0.0925 mL0.4624 mL0.9248 mL4.6242 mL
50 mM0.0370 mL0.1850 mL0.3699 mL1.8497 mL
100 mM0.0185 mL0.0925 mL0.1850 mL0.9248 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PROTAC PTK6 ligand-1 | purchase PROTAC PTK6 ligand-1 | PROTAC PTK6 ligand-1 cost | order PROTAC PTK6 ligand-1 | PROTAC PTK6 ligand-1 chemical structure | PROTAC PTK6 ligand-1 formula | PROTAC PTK6 ligand-1 molecular weight